Adenocarcinoma Of Esophagus Active Not Recruiting Phase 3 Trials for Trastuzumab (DB00072)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

DBCOND0067383 (Adenocarcinoma Of Esophagus)Active Not Recruiting3 IdentifierTitlePurposeDrugs
NCT01196390Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal CancerTreatment